Conference Chairs
Michael Graner Professor, University of Colorado Anschutz School of Medicine |
Mei He Associate Professor, University of Florida |
Keynote Speakers
Lucia Languino Professor of Cancer Biology, Thomas Jefferson University |
Andrew Godwin Professor and Division Director, Genomic Diagnostics, Founding Director, Kansas Institute for Precision Medicine, Deputy Director, KU Cancer Center, University of Kansas Medical Center |
Terry Morgan Professor of Pathology and Laboratory Medicine, Oregon Health and Science University |
Shilpa Buch Professor and Senior Executive Vice Chair for Research, University of Nebraska Medical Center |
Fatah Kashanchi Professor and Director of Research, Lab of Molecular Virology, George Mason University |
Kristin Kopperud Science Program Director, Biological Sciences, International Space Station National Laboratory |
|
Dominique PV de Kleijn Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands |
OverviewSelectBIO is delighted to welcome you to the Extracellular Vesicles 2023 Conference: From Technologies to Biomarker Cargo to Diagnostics. This conference is being held July 26-27, 2023 in Orlando, Florida close to the Walt Disney World Resort and Attractions. SelectBIO is honored to welcome Professor Mei He, University of Florida as Conference Chairperson. This conference brings together academic and industry participants for a 2-day deep dive into timely topics in the Extracellular Vesicles (EVs) field with emphasis on technologies for isolation and study of extracellular vesicles as well as the downstream studies in the EV field such as therapeutics development. In addition to the biomarker and diagnostic potential of EVs, we explore at this conference the latest work and developments in EV-based Therapeutics and the Drug Delivery and Therapeutics Opportunities in the EV Field. Presentations at this conference from academics as well as industry participants and the goal is 2-days of scientific exchange as well as networking opportunities. We welcome exhibitors and companies in the field to engage and participate at this conference and showcase their latest developments and offerings to the field. **This is a 2-Track Conference with Attendees Accessing All 2-Tracks** - One Track Focuses on EV Technologies, Biomarkers & Diagnostics
- The Other Track Focuses on EV-based Drug Delivery, Biologics and Therapeutics Development
Agenda Topics- Biomarker Content of Extracellular Vesicles and Role for Diagnostics Development
- Proteins and Lipids
- Small RNAs such as microRNA Cargo within EVs
- Technologies for Study of EV RNA Cargo such as RNA-Seq
- Disease Areas where EV-based Diagnostics Being Developed
- Single Extracellular Vesicle (EV) Analysis by Flow Cytometry
- Technologies for the Isolation, Characterization and Study of Extracellular Vesicles (EVs)-Exosomes
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateSuren Dhadi, Applications Scientist, NanoFCM Jean-Luc Fraikin, CEO, Spectradyne Hyungsoon Im, Associate Professor, Center for Systems Biology, Mass General Hospital (MGH)/Harvard Medical School Gerardo Kaplan, Principal Investigator, FDA Sven Rudolf Kreutel, Chief Executive Officer, Particle Metrix GmbH and CEO, Particle Metrix Inc., USA Nasser Nassiri Koopaei, CEO, EriVan Bio Anna Testa, Medical Resident, Thomas Jefferson University; Internal Medicine Fellow, University of Tur Robert Thacker, Imaging Sales and Applications Specialist, Cytek Biosciences Liang Wang, Senior Member of Tumor Biology, Moffitt Cancer Center Yong Zeng, Associate Professor, Department of Chemistry, University of Florida
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|